President Donald Trump (NBC News)
WASHINGTON - The Trump administration on Thursday boldly reversed an Obama-era policy that supporters said had helped lower prices for some costly drugs. The policy centers on so-called biosimilar drugs, which are highly similar versions of biologic drugs manufactured in living cells or microorganisms.
Report typos and corrections to corrections@rawstory.com.
For customer support contact support@rawstory.com.
